Stage IB Nonsmall Cell Lung Cancers: Are They All the Same? Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Chemotherapy, Adjuvant
  • Lung Neoplasms
  • Neoplasm Staging

abstract

  • There is significant heterogeneity in the T2N0 class of nonsmall cell lung cancer. Risk stratification using specific histopathologic variables may help determine which patients will benefit most from adjuvant therapy.

publication date

  • June 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.athoracsur.2005.12.054

PubMed ID

  • 16731113

Additional Document Info

start page

  • 1958

end page

  • 62; discussion 1962

volume

  • 81

number

  • 6